UBS’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$9.33M Sell
286,823
-176,039
-38% -$5.98M 0.01% 1508
2014
Q2
$16.2M Buy
462,862
+424,556
+1,108% +$13.9M 0.01% 1004
2014
Q1
$1.21M Sell
38,306
-33,454
-47% -$930K ﹤0.01% 3294
2013
Q4
$1.82M Sell
71,760
-11,262
-14% -$270K ﹤0.01% 2901
2013
Q3
$1.77M Sell
83,022
-16,116
-16% -$331K ﹤0.01% 2713
2013
Q2
$1.92M Buy
+99,138
New +$2.16M ﹤0.01% 2583

Other funds holding PTEN

UBS's PTEN Position: Q3 2014 in Review

UBS reduced its Patterson-UTI (PTEN) stake by 38% in Q3 2014, selling an estimated $5.98M and leaving 286,823 shares worth $9.33M. The position accounts for 0.01% of the portfolio, ranked #1508.

UBS first reported a position in PTEN in Q2 2013 and has held it in 6 quarters since. The position peaked at $16.2M in Q2 2014. 329 funds tracked by Wall St. Rank hold PTEN as of Q3 2014.

  • UBS held 286,823 shares of Patterson-UTI worth $9.33M as of Q3 2014.
  • UBS sold 176,039 Patterson-UTI shares in Q3 2014, an estimated $5.98M.
  • Patterson-UTI made up 0.01% of UBS's portfolio in Q3 2014, its #1508 holding.
  • UBS first reported a position in Patterson-UTI in Q2 2013 and has held it in 6 quarters since.
  • UBS's Patterson-UTI position peaked at $16.2M in Q2 2014.
  • 329 funds tracked by Wall St. Rank held Patterson-UTI as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.